Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,193 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Chimerix Inc | CMRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.019 | 2.13% | 0.91 | 08:48:29 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.891 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 13 | 1,193 | - | 0.88 - 1.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:51:51 | 50 | $ 0.91 | USD |
Chimerix Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 79.4M | 89.21M | - | 324k | -82.1M | -0.92 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Chimerix News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CMRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.94 | 0.94 | 0.88 | 0.8995913 | 234,431 | -0.03 | -3.19% |
| 1 Month | 1.05 | 1.07 | 0.88 | 0.9612061 | 291,032 | -0.14 | -13.33% |
| 3 Months | 0.9201 | 1.30 | 0.88 | 1.06 | 449,197 | -0.0101 | -1.10% |
| 6 Months | 0.95 | 1.30 | 0.88 | 1.01 | 400,420 | -0.04 | -4.21% |
| 1 Year | 1.15 | 1.57 | 0.88 | 1.14 | 648,683 | -0.24 | -20.87% |
| 3 Years | 8.66 | 9.29 | 0.88 | 2.88 | 1,348,188 | -7.75 | -89.49% |
| 5 Years | 2.53 | 11.5696 | 0.88 | 3.22 | 1,070,598 | -1.62 | -64.03% |
Chimerix Description
| Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals. |
